Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.8B | 2.5B | 3.3B | 3.3B |
Cost of revenue | 2.1B | 1.7B | 2.1B | 2.0B |
Gross profit | 652M | 841M | 1.3B | 1.2B |
Operating expense | ||||
Research & development | 365M | 489M | 523M | 492M |
Selling general and admin | 461M | 390M | 420M | 385M |
Other operating expenses | -57M | — | — | — |
Operating income | -73M | -38M | 310M | 351M |
Non operating interest income | ||||
Income | -12M | 62M | 72M | 75M |
Expense | 29M | 14M | 20M | 20M |
Other income expense | 25M | 62M | 56M | 26M |
Pretax income | -14M | 72M | 418M | 432M |
Tax provision | -6M | 13M | 82M | 71M |
Net income | -8M | 59M | 336M | 361M |
Basic EPS | -0.1 | 0.1 | 0.4 | 0.4 |
Diluted EPS | -0.1 | 0.1 | 0.4 | 0.4 |
Basic average shares | 881.8M | 896.1M | 897.4M | 902.3M |
Diluted average shares | 893.9M | 933.6M | 935.7M | 938.6M |
EBITDA | 552M | 494M | 897M | 746M |
Net income from continuing op. | -8M | 59M | 336M | 100M |
Minority interests | -2M | -3M | 5M | -10M |
Preferred stock dividends | — | — | — | — |